Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.
Melanoma Res. 2016 Jun;26(3):278-83. doi: 10.1097/CMR.0000000000000254.
Melanoma Res. 2016.
PMID: 26958991
Free PMC article.
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.
García-Carbonero R, Mayordomo JI, Tornamira MV, López-Brea M, Rueda A, Guillem V, Arcediano A, Yubero A, Ribera F, Gómez C, Trés A, Pérez-Gracia JL, Lumbreras C, Hornedo J, Cortés-Funes H, Paz-Ares L.
García-Carbonero R, et al. Among authors: tornamira mv.
J Natl Cancer Inst. 2001 Jan 3;93(1):31-8. doi: 10.1093/jnci/93.1.31.
J Natl Cancer Inst. 2001.
PMID: 11136839
Free article.
Clinical Trial.
Item in Clipboard
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.
Escobar Y, Cajaraville G, Virizuela JA, Álvarez R, Muñoz A, Olariaga O, Tamés MJ, Muros B, Lecumberri MJ, Feliu J, Martínez P, Adansa JC, Martínez MJ, López R, Blasco A, Gascón P, Calvo V, Luna P, Montalar J, Del Barrio P, Tornamira MV.
Escobar Y, et al. Among authors: tornamira mv.
Support Care Cancer. 2015 Sep;23(9):2833-40. doi: 10.1007/s00520-015-2809-3. Epub 2015 Jun 17.
Support Care Cancer. 2015.
PMID: 26081597
Free PMC article.
Item in Clipboard
Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.
Escobar Y, Cajaraville G, Virizuela JA, Álvarez R, Muñoz A, Olariaga O, Tamés MJ, Muros B, Lecumberri MJ, Feliu J, Martínez P, Adansa JC, Martínez MJ, López R, Blasco A, Gascón P, Calvo V, Luna P, Montalar J, Del Barrio P, Tornamira MV.
Escobar Y, et al. Among authors: tornamira mv.
Support Care Cancer. 2015 Sep;23(9):2841. doi: 10.1007/s00520-015-2842-2.
Support Care Cancer. 2015.
PMID: 26166000
Free PMC article.
No abstract available.
Item in Clipboard
High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
Pérez-Gracia JL, Colomer R, Ruiz-Casado A, Arcediano A, Tornamira MV, Gómez-Martin C, Valentin V, Mendiola C, Cortés-Funes H, Hornedo J.
Pérez-Gracia JL, et al. Among authors: tornamira mv.
Bone Marrow Transplant. 2001 Jan;27(2):117-23. doi: 10.1038/sj.bmt.1702751.
Bone Marrow Transplant. 2001.
PMID: 11281378
Clinical Trial.
Item in Clipboard
Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A, Amador ML, González-Cortijo L, Tornamira MV, Ropero S, Valentín V, Hornedo J, Cortés-Funes H, Colomer R.
Jimeno A, et al. Among authors: tornamira mv.
Cancer. 2004 May 1;100(9):1833-42. doi: 10.1002/cncr.20204.
Cancer. 2004.
PMID: 15112263
Free article.
Item in Clipboard
High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma: a Phase II multicentric trial.
Pérez-Gracia JL, Colomer R, Esteban E, Barceló R, Benavides M, Puertas J, Arcediano A, Tornamira MV, Valentín V, Muñoz A, Cortés-Funes H, Hornedo J.
Pérez-Gracia JL, et al. Among authors: tornamira mv.
Cancer. 2001 Nov 15;92(10):2508-16. doi: 10.1002/1097-0142(20011115)92:10<2508::aid-cncr1601>3.0.co;2-#.
Cancer. 2001.
PMID: 11745183
Clinical Trial.
Item in Clipboard
Cite
Cite